Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 06/30/12
End: 07/31/18
Due: 07/31/19
Phase: N/A
Priority: Normal
Start: 10/31/07
End: 10/31/10
Due: 10/31/11
Phase: N/A
Priority: Normal
Start: 06/30/08
End: 07/31/09
Due: 07/31/10
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Pan-VEGF Blockade for the Treatment of Retinopathy of Prematurity (BLOCK-ROP) | NCT01232777 | Vision Research Foundation | user2@example.com | None | 2012-06-30 | 2018-07-31 | 2019-07-31 | - | - | 2025-07-14 |
| Evaluation of the Effect of Vitreous Composition Determined by Ultrasound and Optical Coherence Tomography (OCT) on Ranibizumab Therapy | NCT01256632 | Vision Research Foundation | user2@example.com | None | 2007-10-31 | 2010-10-31 | 2011-10-31 | - | - | 2025-07-14 |
| Pan-VEGF Blockade for the Treatment of Retinopathy of Prematurity | NCT00702819 | Vision Research Foundation | user2@example.com | None | 2008-06-30 | 2009-07-31 | 2010-07-31 | - | - | 2025-07-14 |